Cargando…

Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha

Recent studies have found that microRNA-29a (miR-29a) levels are significantly lower in fibrotic livers, as shown with human liver cirrhosis. Such downregulation influences the activation of hepatic stellate cells (HSC). Phosphoinositide 3-kinase p85 alpha (PI3KP85α) is implicated in the regulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ya-Ling, Wang, Feng-Sheng, Lin, Hung-Yu, Huang, Ying-Hsien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279217/ https://www.ncbi.nlm.nih.gov/pubmed/32455716 http://dx.doi.org/10.3390/ijms21103636

Ejemplares similares

Phosphoinositide 3-kinase p85beta regulates invadopodium formation
por: Cariaga-Martínez, Ariel E., et al.
Publicado: (2014)

p85β increases phosphoinositide 3-kinase activity and accelerates tumor progression
por: González-García, Ana, et al.
Publicado: (2012)

Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries
por: Li, Sung-Chou, et al.
Publicado: (2016)

Peroxisome Proliferator-Activated Receptor Gamma Agonist Attenuates Liver Fibrosis by Several Fibrogenic Pathways in an Animal Model of Cholestatic Fibrosis
por: Alatas, Fatima Safira, et al.
Publicado: (2020)

Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase
Publicado: (1995)

Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011)

MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice
por: Lin, Hung-Yu, et al.
Publicado: (2019)

Cytochrome P450 Omega-Hydroxylase 4a14 Attenuates Cholestatic Liver Fibrosis
por: Li, Sha, et al.
Publicado: (2021)

Reversine attenuates cholestatic ductular reaction in rats
por: Huang, Di, et al.
Publicado: (2023)

Non-Invasive Imaging of Phosphoinositide-3-Kinase-Catalytic-Subunit-Alpha (PIK3CA) Promoter Modulation in Small Animal Models
por: Gaikwad, Snehal M., et al.
Publicado: (2013)

The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex
por: Luo, Ji, et al.
Publicado: (2005)

C-SH2 point mutation converts p85β regulatory subunit of phosphoinositide 3-kinase to an anti-aging gene
por: Kano, Yoshio, et al.
Publicado: (2019)

Autoinhibition and regulation by phosphoinositides of ATP8B1, a human lipid flippase associated with intrahepatic cholestatic disorders
por: Dieudonné, Thibaud, et al.
Publicado: (2022)

Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
por: Stevens, K N, et al.
Publicado: (2011)

Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
por: Huang, Xueqin, et al.
Publicado: (2023)

Autophosphorylation of serine 608 in the p85 regulatory subunit of wild type or cancer-associated mutants of phosphoinositide 3-kinase does not affect its lipid kinase activity
por: Layton, Meredith J, et al.
Publicado: (2012)

Upregulation of cadherin‐11 contributes to cholestatic liver fibrosis
por: Wu, Bo, et al.
Publicado: (2022)

Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice
por: Kennedy, Lindsey, et al.
Publicado: (2016)

Phosphoinositide-3-Kinase Is the Primary Mediator of Phosphoinositide-Dependent Inhibition in Mammalian Olfactory Receptor Neurons
por: Ukhanov, Kirill, et al.
Publicado: (2016)

The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond
por: Lin, Hung-Yu, et al.
Publicado: (2020)

MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases
por: Yang, Ya-Ling, et al.
Publicado: (2017)

Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α
por: Burke, John E., et al.
Publicado: (2011)

Non-catalytic role of phosphoinositide 3-kinase in mesenchymal cell migration through non-canonical induction of p85β/AP-2-mediated endocytosis
por: Matsubayashi, Hideaki T., et al.
Publicado: (2023)

Non-catalytic role of phosphoinositide 3-kinase in mesenchymal cell migration through non-canonical induction of p85β/AP-2-mediated endocytosis
por: Matsubayashi, Hideaki, et al.
Publicado: (2023)

Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia
por: Shey, Susan, et al.
Publicado: (2021)

MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma
por: SONG, SHI-DUO, et al.
Publicado: (2013)

The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
por: Fuji, Hiroaki, et al.
Publicado: (2021)

The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis
por: Huang, Ying-Hsien, et al.
Publicado: (2018)

Regulation of heart rate and the pacemaker current by phosphoinositide 3-kinase signaling
por: Lin, Richard Z., et al.
Publicado: (2019)

Electroacupuncture attenuates chronic fibromyalgia pain through the phosphorylated phosphoinositide 3-kinase signaling pathway in the mouse brain
por: Chen, Chao-Tsung, et al.
Publicado: (2019)

MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation
por: Huang, Ying-Hsien, et al.
Publicado: (2019)

Doxycycline Attenuates Atrial Remodeling by Interfering with MicroRNA-21 and Downstream Phosphatase and Tensin Homolog (PTEN)/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway
por: Zhang, Kai, et al.
Publicado: (2018)

The Role of Phosphoinositide 3-Kinase Signaling in Intestinal Inflammation
por: Cahill, Catherine M., et al.
Publicado: (2012)

The role of phosphoinositide 3-kinase subunits in chronic thyroiditis
por: Wojciechowska-Durczynska, Katarzyna, et al.
Publicado: (2012)

Phosphoinositide 3-kinase: friend and foe in cardiovascular disease
por: Ghigo, Alessandra, et al.
Publicado: (2015)

The phosphoinositide 3-kinase pathway and therapy resistance in cancer
por: Brown, Kristin K., et al.
Publicado: (2015)

Phosphoinositides, kinases and adaptors coordinating endocytosis in Trypanosoma brucei
por: Manna, Paul T, et al.
Publicado: (2016)

Multiple Functions of Phosphoinositide-3 Kinase Enhancer (PIKE)
por: Chan, Chi Bun, et al.
Publicado: (2010)

Class (I) Phosphoinositide 3-Kinases in the Tumor Microenvironment
por: Gyori, David, et al.
Publicado: (2017)

Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition
por: Dewan, Anna K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h7b79re91o107vtqghh5mf331q